The global primary cells market is projected to reach USD
2.8 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 10.5% during the
forecast period. The growth of this market can be attributed to factors such as
the is the growing advantages of primary human cells over cell lines, growth in
pharmaceutical & biotechnology industries, increasing demand for monoclonal
antibodies, government investments for cell-based research, and increasing
cancer research.
Request To
Download Sample of This Strategic Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960
Primary cells refer to cells taken directly from living
tissues of animals or humans and are then processed to establish them for use
in appropriate cell therapies. Primary cells are widely used in various
applications, including 3D cell culture, virology, cancer research, stem cell
therapy, and tissue replacement.
This study involved four major activities in estimating the
current size of the primary cells market. Exhaustive secondary research was
carried out to collect information on the market, its peer markets, and its
parent market. The next step was to validate these findings, assumptions, and
sizing with industry experts across the value chain through primary research.
North America is the largest regional market for primary
cells market
The primary cells market is segmented into four major
regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
(RoW). North America accounted for the largest share in the primary cells
market. The growth in the North American primary cells market can be attributed
to increasing funding for cancer research, growing life science research
sector, expansion of the healthcare sector, and the high adoption of stem cell
therapy & cell immunotherapies for the treatment of cancer and chronic diseases.
Key
Market Players
Thermo Fisher
Scientific, Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), Cell
Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US),
ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated
(US), AllCells (US), American Type Culture Collection (US), Axol Bioscience
Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US),
BioIVT (US), ScienCell Research Laboratories, Inc. (US), PPA Research Group,
Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix Sàrl
(Switzerland), ReachBio LLC (US), AcceGen (US), Sekisui XenoTech, LLC (US), and
Biopredic International (France).
For a detailed look at our Table of Contents
@ https://www.marketsandmarkets.com/Market-Reports/primary-cells-market-32854960.html
This report categorizes the primary cells market into
the following segments and subsegments:
By Origin
By Type
By End User
By Region
Recent Developments
Buy-Now this Premium Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=32854960
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies’ revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies, innovators, strategic players)
annually in high growth emerging segments. MarketsandMarkets™ is determined to
benefit more than 10,000 companies this year for their revenue planning and
help them take their innovations/disruptions early to the market by providing
them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and
market research platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
The Wall